Massive pulmonary thromboembolism demonstrated at necropsy in Japanese psychiatric patients treated with neuroleptics including atypical antipsychotics

被引:45
作者
Hamanaka, S
Kamijo, Y
Nagai, T
Kurihara, K
Tanaka, K
Soma, K
Miyaoka, H
机构
[1] Kitasato Univ, Dept Psychiat, Sch Med, Sagamihara, Kanagawa 2288555, Japan
[2] Kitasato Univ, Dept Emergency & Crit Care Med, Sch Med, Sagamihara, Kanagawa 2288555, Japan
[3] Kitasato Univ, Dept Legal Med, Sch Med, Sagamihara, Kanagawa 2288555, Japan
[4] Kitasato Univ, Grad Sch Med Sci, Dept Occupat Mental Hlth, Sagamihara, Kanagawa 228, Japan
关键词
antiphospholipid antibodies; atypical antipsychotic drugs; phenothiazines; pulmonary thromboembolism;
D O I
10.1253/circj.68.850
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There may be an increased risk of pulmonary thromboembolism (PTE) with antipsychotic drugs, so this association was investigated in autopsy cases of sudden unexpected death determined by the Department of Legal Medicine of a Japanese university hospital. Methods and Results Records of 1, 125 forensic autopsies (808 males, 317 females) performed during the study period for investigation of the cause of sudden unexpected death were reviewed and a logistic regression analysis was performed to explore whether age, gender, body mass index (BMI), and antipsychotic drug use were associated with fatal PTE. Among all records, 34 (3.0%; 14 males, 20 females) indicated the use of antipsychotic drugs and 28 (2.5%; 9 males, 19 females) indicated PTE as the cause of death. Of the 28 subjects who died from PTE, 8 had taken antipsychotic drugs (29%) and all were female. Female gender and antipsychotic drug use accounted for a significantly higher risk of PTE death with an odds ratio of 4.22 (95% confidence interval (0), 1.82-9.78; p < 0.01) and 10.49 (95% CI, 3.95-27.85; p < 0.01), respectively. Conclusions Japanese women taking antipsychotic drugs may be at particular risk for PTE.
引用
收藏
页码:850 / 852
页数:3
相关论文
共 21 条
[11]   THROMBO-EMBOLIC COMPLICATIONS OF PSYCHOPHARMACEUTICALS [J].
MEIEREWERT, K ;
BAUMGART, HH ;
FRIEDENBERG, P .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1967, 92 (47) :2174-+
[12]   Diagnostic and Statistical Manual of Mental Disorders [J].
Mittal, Vijay A. ;
Walker, Elaine F. .
PSYCHIATRY RESEARCH, 2011, 189 (01) :158-159
[13]   Incidence and clinical characteristics of chronic pulmonary thromboembolism in Japan compared with acute pulmonary thromboembolism - Results of a Multicenter registry of the Japanese Society of Pulmonary Embolism Research [J].
Nakamura, M ;
Okada, O ;
Sakuma, M ;
Nakanishi, N ;
Miyahara, Y ;
Yamada, N ;
Fujioka, H ;
Kuriyama, T ;
Kunieda, T ;
Sugimoto, T ;
Nakano, T .
CIRCULATION JOURNAL, 2002, 66 (03) :257-260
[14]  
Sakuma M, 1999, JPN CIRC J, V63, P825
[15]  
TANIFUJI T, 2003, JPN J PHLEBOL, V14, P189
[16]   Antipsychotic medication and venous thrombosis [J].
Thomassen, R ;
Vandenbroucke, JP ;
Rosendaal, FR .
BRITISH JOURNAL OF PSYCHIATRY, 2001, 179 :63-66
[17]   NEUROLEPTIC-RELATED SUDDEN-DEATH (PROVEN OR A MERE HYPOTHESIS) [J].
UNGVARI, G .
PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1980, 13 (01) :29-33
[18]  
Vandenbroucke JP, 1998, THROMB HAEMOSTASIS, V79, P511
[19]   Mortality in current and former users of clozapine [J].
Walker, AM ;
Lanza, LL ;
Arellano, F ;
Rothman, KJ .
EPIDEMIOLOGY, 1997, 8 (06) :671-677
[20]   Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism:: Pilot study [J].
Wallaschofski, H ;
Eigenthaler, M ;
Kiefer, M ;
Donné, M ;
Hentschel, B ;
Gertz, HJ ;
Lohmann, T .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (05) :479-483